| Agilent Technologies is engaged in life sciences, diagnostics and applied chemical markets. Co.'s segments are: Life Sciences and Applied Markets Business, which provides instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products; Diagnostics and Genomics Business, which includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses; and Agilent CrossLab Business, which spans the entire lab with its consumables and services portfolio to improve customer outcomes. We show 53 historical shares outstanding datapoints in our coverage of A's shares outstanding history.|
Understanding the changing numbers of A shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like A versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching A by allowing them to research A shares outstanding history
as well as any other stock in our coverage universe.